BC
DXCM icon

Broadfin Capital’s DexCom DXCM Stock Holding History

Broadfin Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-253,200
Closed -$9.48M – 45
2019
Q2 		$9.48M Sell
253,200
-16,800
-6% -$528K 2.06% 17
2019
Q1 		$8.04M Sell
270,000
-449,600
-62% -$15.8M 1.66% 24
2018
Q4 		$21.6M Buy
719,600
+622,800
+643% +$19.8M 2.83% 10
2018
Q3 		$3.46M Buy
+96,800
New +$3M 0.51% 40
2017
Q2 		– Sell
-197,200
Closed -$4.18M – 57
2017
Q1 		$4.18M Buy
+197,200
New +$3.85M 0.51% 40

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Broadfin Capital's DXCM Position: Q3 2019 in Review

Broadfin Capital sold out of DexCom (DXCM) in Q3 2019, closing a stake of 253,200 shares — an estimated $9.48M sold.

Broadfin Capital first reported a position in DXCM in Q1 2017 and held it in 5 quarters. The position peaked at $21.6M in Q4 2018. 423 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

  • Broadfin Capital reported no remaining DexCom position as of Q3 2019 after selling out during the quarter.
  • Broadfin Capital sold 253,200 DexCom shares in Q3 2019, an estimated $9.48M.
  • Broadfin Capital first reported a position in DexCom in Q1 2017 and held it in 5 quarters.
  • Broadfin Capital's DexCom position peaked at $21.6M in Q4 2018.
  • 423 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on Broadfin Capital's 13F filing for Q3 2019, filed 14 Nov 2019.